ARROWHEAD PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Adjustments to Additional Paid in Capital, Warrant Issued of $100.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-04
- ARROWHEAD PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2026-03-31 was $100.00M.
- ARROWHEAD PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-12-31 was $25.00M.
- ARROWHEAD PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $25.00M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2026-03-31 | $100.00M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $25.00M 10-K · filed 2025-11-25 | |
| 2024-12-31 | $25.00M 10-Q · filed 2026-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |